Zhongshan Hygene Biopharm Co., Ltd.

In 2004, Zhongshan Hygene Biopharm Co., Ltd., (originally known as Shanghai Hygene Biopharm Co., Ltd. ) was set up in Zhongshan National Health Base with registered capital of RMB 5 million. Business scopes: Production and sales of genetic recombination products (recombinant human growth hormone for injection), as well as research of biological products.

Zhongshan Hygene Biopharm Co., Ltd. Took about one year to complete the overall construction of the modernized factory in July, 2005. At present, the company has 1270M2 of administrative offices and 1620M2 of all-in-one workshop which is in accordance with the requirements of GMP, established and improved the production and operation management system, won the "Certificate of Pharmaceutical GMP, " and "Drug Production License, " issued by the State Food and Drug Administration and formally put into production. The company won the honor of "Guangdong Hi-tech Enterprise" in May, 2006 and "Guangdong Private Technology Enterprise" in November, 2006. After being put into production operation, the company achieved a remarkable business performance in the very year and became the rising star of China′s biopharmaceutical industry.

Thus, the company, from the R&D and pilot test of genetic engineering drugs conducted by the former company in 1995 to the current success of industrial and commercial operation, has experienced a hone for 10 years, completed the accumulation process of technology and business management and stepped from the phase of "Three high, One long" (high input, high-risk, high-yield, long-cycle) into the high-growing phase of the enterprise.